


for the event


requirementsand quality measures
personnel in the effort to push health equity to the next level
Vaccination Program for Employees & Staff

TrueCare24 receives allocation of vaccines

The site receives
vaccines supplies

Event fulfillment or end-to-end execution

TrueCare24 arrives on-site for event and potentially the end-to-end execution

TrueCare24 manages reporting to County,
State & Federal
Vaccination Program for Employees & Staff

The site receives
all the necessary vaccines supplies

TrueCare24 arrives on-site for event and
ETE execution

TrueCare24 manages reporting to Federal/State/County
Why to Use SARS-Cov-2 Vaccines?

Vaccines Protect You
and People Around You

Vaccines Help To Stop
Spreading The Virus

Vaccines Work and Serious
Side Effects Are Rare
Why to Use SARS-Cov-2 Vaccines?
TrueCare24
Trusted by:

Samantha Rudin the Rudin Management senior vice president


Jared Plois Governor of Colorado


Julie L. Ramsey Vice President of college and Dean of Students


TrueCare24
Trusted By:

Samantha Rudin the Rudin Management senior vice president


Jared Plois Governor of Colorado


Julie L. Ramsey Vice President of college and Dean of Students

Direct Patient Vaccination Flow
Step 1
Visit registration
website
Step 2
Complete
assesment
Step 3
Schedule
first dose
Step 4
Receive reminder
for first dose
Step 5
Scan QR code and
receive first dose
Step 9
Receive your vaccination
passport
Step 8
Scan QR code and receive your second dose
Step 7
Receive a reminder
to schedule second dose
REACTION?
IF YES: on-site
medical practitioner to assist
Step 6
Receive patient experience survey
website
Direct Patient Vaccination Flow
Step 1
Visit registration
website
Step 2
Complete
assesment
Step 3
Schedule
first dose
Step 4
Receive reminder
for first dose
Step 5
Scan QR code and
receive first dose
Step 6
Receive patient experience survey
website
REACTION?
IF YES: on-site
medical practitioner to assist
Step 7
Receive a reminder
to schedule second dose
Step 8
Scan QR code and receive your second dose
Step 9
Receive your vaccination
passport
Frequently Asked Questions
1IS IT SAFE TO USE VACCINES?
Is the vaccine being rushed out too fast? Then how safe it is?
Typically, it takes years to develop a vaccine, but it took only months How was this possible ?
- Advanced technology
- Prior vaccine research
- Collaboration between the agencies
- The number of resources that were provided
- Clinical trials are being conducted according to the rigorous
standards set forth by FDA
- Advanced technology
- Prior vaccine research
- Collaboration between the agencies
- The number of resources that were provided
- Clinical trials are being conducted according to the rigorous
standards set forth by FDA
2WHATS THE PROCESS?
- FDA advisory committee votes
-FDA determines that a vaccine meets its safety and effectiveness standards
- After FDA makes its determination, the Advisory Committee on Immunization Practices (ACIP) will review available data before making vaccine recommendations to CDC
- ACIP reviews data
Age, race, ethnicity, underlying medical conditions
How different groups respond to the vaccine
Side effects experienced
- The U.S. vaccine safety system ensures that all vaccines are as safe as possible
-FDA determines that a vaccine meets its safety and effectiveness standards
- After FDA makes its determination, the Advisory Committee on Immunization Practices (ACIP) will review available data before making vaccine recommendations to CDC
- ACIP reviews data
Age, race, ethnicity, underlying medical conditions
How different groups respond to the vaccine
Side effects experienced
- The U.S. vaccine safety system ensures that all vaccines are as safe as possible
3WHAT ARE THE 5 COVID-19 VACCINES AVAILABLE IN THE US?
- Pfizer-BioNTech’s COVID-19 vaccine - FDA approved for EUA on 12/11/20
- Moderna’s COVID-19 vaccine- FDA approved for EUA on 12/18/20
- Janssen’s COVID-19 vaccine - Single-Dose COVID-19 Vaccine - FDA EUA on 2/27/21
- Novavax’s COVID-19 vaccine- expected in April
- AstraZeneca’s COVID-19 vaccine- adenovirus-based vaccine - expected April
- Moderna’s COVID-19 vaccine- FDA approved for EUA on 12/18/20
- Janssen’s COVID-19 vaccine - Single-Dose COVID-19 Vaccine - FDA EUA on 2/27/21
- Novavax’s COVID-19 vaccine- expected in April
- AstraZeneca’s COVID-19 vaccine- adenovirus-based vaccine - expected April
4HOW mRNA VACCINES WORK
- mRNA vaccines do not use the live virus that causes COVID-19.
- mRNA never enters the nucleus of the cell, which is where our
- DNA (genetic material) is kept.
- The cell breaks down and gets rid of the mRNA soon after it is finished using the instructions.
- mRNA never enters the nucleus of the cell, which is where our
- DNA (genetic material) is kept.
- The cell breaks down and gets rid of the mRNA soon after it is finished using the instructions.
5AUTHORIZED AGE GROUP
Pfizer-BioNTech’s COVID-19 vaccine - 16 years and older
Moderna’s COVID-19 vaccine - 18 years and older
Moderna’s COVID-19 vaccine - 18 years and older
6WHAT IS THE DOSING SCHEDULE?
Pfizer-BioNTech’s COVID-19 vaccine - 21 DAYS
Moderna’s COVID-19 vaccine - 28 DAYS
Moderna’s COVID-19 vaccine - 28 DAYS
7ADVERSE REACTIONS IN STUDIES
Pain at the injection site (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%), injection site swelling (10.5%), injection site redness (9.5%), nausea (1.1%), malaise (0.5%), and lymphadenopathy (0.3%)
Most of the severe side effects occurred after participants got the second dose
Side effects were more common among younger participants Among people aged 18 to 55
4.6% reported severe fatigue after getting their second injection 3.2% had severe headaches
15.8% had fever
Among volunteers older than 55
2.8% reported severe fatigue
0.5% experienced severe headaches after the second dose 10.9% had a fever
Most of the severe side effects occurred after participants got the second dose
Side effects were more common among younger participants Among people aged 18 to 55
4.6% reported severe fatigue after getting their second injection 3.2% had severe headaches
15.8% had fever
Among volunteers older than 55
2.8% reported severe fatigue
0.5% experienced severe headaches after the second dose 10.9% had a fever
8ADMINISTRATION AND STORAGE
Pfizer-BioNTech
95% effective(52% after first dose)
IM inj
Each vial has 5 doses
Need to dilute
No preservative
Store in the freezer at -70F
Moderna
94.1% effective(80-90% after first dose)
IM inj
Each vial has 10 doses
No need to dilute
No preservative
Store in the freezer at -4F
95% effective(52% after first dose)
IM inj
Each vial has 5 doses
Need to dilute
No preservative
Store in the freezer at -70F
Moderna
94.1% effective(80-90% after first dose)
IM inj
Each vial has 10 doses
No need to dilute
No preservative
Store in the freezer at -4F
FAQs

1IS IT SAFE TO USE VACCINES?
Is the vaccine being rushed out too fast? Then how safe it is?
Typically, it takes years to develop a vaccine, but it took only months How was this possible ?
- Advanced technology
- Prior vaccine research
- Collaboration between the agencies
- The number of resources that were provided
- Clinical trials are being conducted according to the rigorous
standards set forth by FDA
- Advanced technology
- Prior vaccine research
- Collaboration between the agencies
- The number of resources that were provided
- Clinical trials are being conducted according to the rigorous
standards set forth by FDA
2WHATS THE PROCESS?
- FDA advisory committee votes
-FDA determines that a vaccine meets its safety and effectiveness standards
- After FDA makes its determination, the Advisory Committee on Immunization Practices (ACIP) will review available data before making vaccine recommendations to CDC
- ACIP reviews data
Age, race, ethnicity, underlying medical conditions
How different groups respond to the vaccine
Side effects experienced
- The U.S. vaccine safety system ensures that all vaccines are as safe as possible
-FDA determines that a vaccine meets its safety and effectiveness standards
- After FDA makes its determination, the Advisory Committee on Immunization Practices (ACIP) will review available data before making vaccine recommendations to CDC
- ACIP reviews data
Age, race, ethnicity, underlying medical conditions
How different groups respond to the vaccine
Side effects experienced
- The U.S. vaccine safety system ensures that all vaccines are as safe as possible
3WHAT ARE THE 5 COVID-19 VACCINES AVAILABLE IN THE US?
- Pfizer-BioNTech’s COVID-19 vaccine - FDA approved for EUA on 12/11/20
- Moderna’s COVID-19 vaccine- FDA approved for EUA on 12/18/20
- Janssen’s COVID-19 vaccine - Single-Dose COVID-19 Vaccine - FDA EUA on 2/27/21
- Novavax’s COVID-19 vaccine- expected in April
- AstraZeneca’s COVID-19 vaccine- adenovirus-based vaccine - expected April
- Moderna’s COVID-19 vaccine- FDA approved for EUA on 12/18/20
- Janssen’s COVID-19 vaccine - Single-Dose COVID-19 Vaccine - FDA EUA on 2/27/21
- Novavax’s COVID-19 vaccine- expected in April
- AstraZeneca’s COVID-19 vaccine- adenovirus-based vaccine - expected April
4HOW mRNA VACCINES WORK
- mRNA vaccines do not use the live virus that causes COVID-19.
- mRNA never enters the nucleus of the cell, which is where our
- DNA (genetic material) is kept.
- The cell breaks down and gets rid of the mRNA soon after it is finished using the instructions.
- mRNA never enters the nucleus of the cell, which is where our
- DNA (genetic material) is kept.
- The cell breaks down and gets rid of the mRNA soon after it is finished using the instructions.
5AUTHORIZED AGE GROUP
Pfizer-BioNTech’s COVID-19 vaccine - 16 years and older
Moderna’s COVID-19 vaccine - 18 years and older
Moderna’s COVID-19 vaccine - 18 years and older
6WHAT IS THE DOSING SCHEDULE?
Pfizer-BioNTech’s COVID-19 vaccine - 21 DAYS
Moderna’s COVID-19 vaccine - 28 DAYS
Moderna’s COVID-19 vaccine - 28 DAYS
7ADVERSE REACTIONS IN STUDIES
Pain at the injection site (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%), injection site swelling (10.5%), injection site redness (9.5%), nausea (1.1%), malaise (0.5%), and lymphadenopathy (0.3%)
Most of the severe side effects occurred after participants got the second dose
Side effects were more common among younger participants Among people aged 18 to 55
4.6% reported severe fatigue after getting their second injection 3.2% had severe headaches
15.8% had fever
Among volunteers older than 55
2.8% reported severe fatigue
0.5% experienced severe headaches after the second dose 10.9% had a fever
Most of the severe side effects occurred after participants got the second dose
Side effects were more common among younger participants Among people aged 18 to 55
4.6% reported severe fatigue after getting their second injection 3.2% had severe headaches
15.8% had fever
Among volunteers older than 55
2.8% reported severe fatigue
0.5% experienced severe headaches after the second dose 10.9% had a fever
8ADMINISTRATION AND STORAGE
Pfizer-BioNTech
95% effective(52% after first dose)
IM inj
Each vial has 5 doses
Need to dilute
No preservative
Store in the freezer at -70F
Moderna
94.1% effective(80-90% after first dose)
IM inj
Each vial has 10 doses
No need to dilute
No preservative
Store in the freezer at -4F
95% effective(52% after first dose)
IM inj
Each vial has 5 doses
Need to dilute
No preservative
Store in the freezer at -70F
Moderna
94.1% effective(80-90% after first dose)
IM inj
Each vial has 10 doses
No need to dilute
No preservative
Store in the freezer at -4F